Semglee (insulin glargine-yfgn) is biosimilar to and interchangeable with Lantus (insulin glargine) and provides a cost-effective option.
FDA OKs marketing of new test to help diagnose Alzheimer disease
May 06, 2022
The test is indicated for patients 55 years and older who present with cognitive impairment and are being evaluated for Alzheimer’s disease and cognitive decline.
Coronary artery bypass grafting feasible in patients over 80
Jun 28, 2022
The procedure extends long-term survival but carries surgical risks.
Medicare now covers COVID-19 tests bought at drug stores
Apr 05, 2022
Now the 59 million Americans covered by Medicare Part B can get up to eight free, at-home tests each month.
Specific plasma metabolites linked to cognitive function
Sep 19, 2022
Diet-related metabolites are associated with global cognitive function across studies in adults of various races/ethnicities.
Heart surgery patients may not need opioids at home
Dec 27, 2021
Older age, longer length of hospital stay and undergoing surgery during the past three months of the study were independent predictors of discharge without an opioid prescription.
Which cancer patients need a COVID-19 booster shot most?
Sep 07, 2021
National Comprehensive Cancer Network Vaccination Advisory Committee guidance says several groups should be considered eligible immediately for a third dose of either of the mRNA vaccines.
Merck to ask FDA for emergency approval of its new antiviral pill for COVID-19
Oct 01, 2021
The new medication is just one of several antiviral pills now being tested in studies.